4
Changes in Ownership
Edwards Lifesciences Corp Filed Acc 0001225208-24-005004
CVP,Strategy/Corp Development sold 12,500 shares at an average $92.33 ($1,154,142)
- CVP,Strategy/Corp Development acquired 12,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
BOBO DONALD E JR · CVP,Strategy/Corp Development
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-04-08 | Exercise or conversion : show line 1 in the form 10b5-1 | +12,500 | $36.75 | $459,375 | 52,267.72 | D |
| 2024-04-08 | Sale : show line 2 in the form 10b5-1 | −100 | $92.66 | $9,266 | 52,167.72 | D |
| 2024-04-08 | Sale : show line 3 in the form 10b5-1 | −12,400 | $92.33 | $1,144,876 | 39,767.72 | D |
| Open-market sales · 12,500 sh · avg $92.33 · $1,154,142 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2024-04-08 | Exercise or conversion : show line 4 in the form 10b5-1 Employee Stock Option (Right to Acquire) | −12,500 | $36.75 | 2024-05-10 | 12,500 | 0 | D |
Loading xslF345X05/doc4.xml…